A ga-akwado ihe nṅomi 200 mbụ!Ekpughere ngwaahịa nṅomi na-ekpo ọkụ nke nnukwu ụlọ ọrụ.

1.Azụmahịa mgbasawanye: Yuyue ọgwụ re acquisition, 100% jide

N'oge na-adịbeghị anya, ngwa nyocha ụlọ ọrụ na-egosi na Jiangsu Lerun kọntaktị lens Co., Ltd. emeela mgbanwe ụlọ ọrụ na azụmahịa, ndị mbụ na-eketa Jiangsu Hongyi Garden Construction Engineering Co., Ltd. na Danyang xintongqiu optical glasses Co., Ltd. wepụrụ, na onye na-eketa òkè ọhụrụ Yuyue medical (002223) na-ejide 100%.Ọ bara uru ịkọwa na ka n'oge dị ka 2019, Yuyue mefuru ihe fọrọ nke nta ka ọ bụrụ nde yuan 80 iji nweta ụlọ ọrụ igwe anya abụọ.

2.Na Mee 24, webụsaịtị gọọmentị nke Zhejiang Pharmaceutical Machinery Procurement Center weputara ọkwa na ogo nke ụlọ nkwakọba ọgwụ na 2021, na ekwupụtala ozi dabara adaba nke ngwaahịa 200 kacha elu.Top10 bụ ụlọ ọrụ ọgwụ mba dị iche iche na-achị, yana mbadamba clopidogrel bisulfate sitere na China Stone Pharmaceutical Group na Europe Italy Pharmaceutical Co., Ltd., ụlọ ọrụ na-emepụta ọgwụ ụlọ, nwere Top11.

3.N'okpuru usoro iwu, ọgwụ ọhụrụ ụlọ ebutela n'oge owuwe ihe ubi kpụ ọkụ n'ọnụ, ụlọ ọrụ na-emepụta ọgwụ abanyekwala n'oge mgbanwe mmega ahụ.Dị ka data nke micnet si kwuo, ebe ọ bụ na 2011, ihe fọrọ nke nta ka ọ bụrụ 90 ụlọ klas 1 ọgwụ ọhụrụ (gụnyere klas 1 na 1.1, ewezuga ọgwụ mgbochi, otu n'okpuru) ka akwadoro maka ịdepụta, na ụlọ ọrụ ọgwụ 15 kwadoro 2 ma ọ bụ karịa ụdị.Uru nke nnukwu pharma ọdịnala bụ ama ama, yana Hengrui kwụsiri ike na mbụ.Ka emechara ya, onye isi biotech adịghị njikere ịpụ ya, yana Baiji Shenzhou, Hehuang ọgwụ na zaiding pharmaceutical ka ejikọtara maka ebe nke atọ.

4.Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., onye enyemaka nke Guangzhou Pharmaceutical Group, otu n'ime ụlọ ọrụ 500 kacha elu n'ụwa, mara ọkwa na mgbede nke May 30 na Baiyunshan Pharmaceutical General Factory natara akwụkwọ ozi sitere na US FDA (ya bụ US Food). na nchịkwa ọgwụ) na Mee 29 na-akwado mbadamba bys10 ka a ga-eji na nnwale ụlọ ọgwụ maka ọgwụgwọ etuto siri ike dị elu na njikọta RET ma ọ bụ mgbanwe.Baiyunshan Pharmaceutical General Factory na-ezube ime nnwale ụlọ ọgwụ mepere emepe nke ọtụtụ etiti etiti nke ọgwụ ọhụrụ maka ihe ngosi ndị dị n'elu mgbe ọnọdụ ahụ ga-ezute n'ọdịnihu dị nso.

5.Ahịa ndị na-ahụ maka ihe dị iche na-eto eto ọzọ.Kelun pharmaceutical emeriela nṅomi mbụ na ọgwụ Hengrui ịga n'oké osimiri.Dabere na data nke Intranet, na 2021, ọnụ ahịa ụlọ ọrụ ahụike ọha na China karịrị ijeri yuan 17, mmụba kwa afọ nke 13.05%;Hengrui pharmaceutical, General Electric pharmaceutical na Yangtze River Pharmaceutical họọrọ n'etiti atọ kacha;Ọnụ ahịa nke ngwaahịa ise karịrị 1billion yuan, nke ntụ ntụ iodixanol na-edu.Ka ọ dị ugbu a, a na-enyocha ụdị 10 dị iche iche (nkọwa 40), na iodophor ezutewo ọnọdụ maka nchịkọta etiti;Ụdị 12 dị iche iche (nkọwapụta ngwaahịa 23) dị n'ahịa maka nyocha, na Beite pharmaceutical bụ onye mbụ na-eṅomi ha.

6.Na June 7, Huiyu pharmaceutical kwupụtara na enyemaka nke Seacross pharmaceuticals' prosafel injection nwetara nkwado ndebanye aha na UK, na-eme ka ọ bụrụ ụlọ ọrụ mbụ nwetara nkwado nke ọgwụ jeneriki na UK.Kemgbe afọ a, a kwadoro ngwaahịa ọgwụ ọgwụ Huiyu n'ụlọ na ná mba ọzọ.

7.A ga-akwado ihe nṅomi 200 mbụ!Ekpughere ngwaahịa nṅomi na-ekpo ọkụ nke nnukwu ụlọ ọrụ.

N'ime afọ ndị na-adịbeghị anya, a na-akwado ọgwụ ndị mbụ jeneriki na ọkwa mba.Ka ọ na-arụsi ọrụ ike na-ekesa ọgwụ ọhụrụ, ụlọ ọrụ ndị na-emepụta ọgwụ na-ahụ maka ọgwụ nwere ọkwa R & D dị elu emeela ka ọrụ "iṅomi" dịkwuo ngwa ngwa.Kemgbe 2018, enwere ihe dị ka ngwaahịa 200 etinyere maka ndepụta nṅomi ma na-enyocha ya, ọ dịghịkwa nkwenye ụlọ enwetara maka otu ngwaahịa ahụ.A na-atụ anya na a ga-akwado ha maka ndepụta mgbe 2022 gachara, yana ọkụ ahịa ahịa narị ijeri ise kacha elu.

8.Humanwell na-egosi ike ya!20 klas 1 ọgwụ ọhụrụ na 18 emelitere ọgwụ ọhụrụ dị ọkụ.

N'ime afọ ndị na-adịbeghị anya, Humanwell pharmaceutical, onye ndu nke anesthesia na sedation, na-aga n'ihu na-emewanyewanye ma na-eme ka asọmpi ya dị elu site na "nlekwasị anya, ihe ọhụrụ na mba ụwa".N'oge na-adịbeghị anya, ụlọ ọrụ ahụ kwupụtara na ọ ga-emefu ihe karịrị ijeri yuan 1.6 ịzụta ihe onwunwe iji jikọta ihe onwunwe dị n'ime ma gbasaa ike ya.N'ime ha, a ga-eji akụ ihe onwunwe nke ụlọ ọrụ nyocha ọgwụ ọhụrụ na mmepe mmepe zụtara dị ka ntọala "oke ọchụnta ego na ihe ọhụrụ" biomedical iji mee ka nhazi ihe ọhụrụ pụta.N'ime ọkara mbụ nke 2022, ụlọ ọrụ ahụ nwere ọgwụ ọhụrụ abụọ 1 nke akwadoro maka iji ụlọ ọgwụ eme ihe, ọgwụ ọhụrụ emelitere nke mbụ na-agbaga n'ahịa.Ngosipụta mbụ nke mbadamba ọgwụ chlorbazam ụmụaka dị arọ adọtawokwa nlebara anya nke ukwuu.Na mgbakwunye, ngwaahịa atọ bụ isi na-achọ izute batch nke asaa nke nnweta mba.

9.Zhengda anwụ na-acha!58 klas 1 ọhụrụ ọgwụ na 9 mbụ iṅomi sprints.

N'oge na-adịbeghị anya, ngwaahịa akara nke Zhengda Tianqing pharmaceutical nwere ọganihu ọhụrụ: mmepụta nke tq-b3101 capsule, ọhụrụ klas 1 ọgwụ mgbochi tumor, a kwadoro mbadamba sophopovir nke atọ, yana ịgba ọgwụ tqc2938, klas ọhụrụ 1. ọgwụ mgbochi ụkwara ume ọkụ, akwadoro maka iji ụlọ ọgwụ ugbu a, Zhengda Tianqing Pharmaceutical Co., Ltd. nwere ọgwụ ọhụrụ 73 (58 klas 1 ọgwụ ọhụrụ) na ọkwa nke ngwa ụlọ ọgwụ ma ọ bụ n'elu, nke 14 ọhụrụ ọgwụ (5 klas 1 ọhụrụ). ọgwụ) nọ na ọkwa nke III ma ọ bụ karịa, a na-atụkwa anya ndepụta ahụ;N'ihe gbasara ọgwụ jenerik, enyochala ụdị 54 dị iche iche (21 bụ nke mbụ), abanyela ọgwụ 8 n'ọkwa nke asaa nke ịzụrụ ihe, yana ụdị iri na ise e debanyere aha ọhụrụ na nke ekwuputara na-enyocha, nke 9 na-akwadoghị maka ya. oge mbụ (gụnyere akwụkwọ mbụ nke ụdị onunu ogwu).

JinDun Medicalnwere ogologo oge nnyocha sayensị imekọ ihe ọnụ na nkà na ụzụ grafting na Chinese mahadum.Site na akụrụngwa ọgwụ bara ụba nke Jiangsu, ọ nwere mmekọrịta azụmahịa ogologo oge na India, Ndịda Ebe Ọwụwa Anyanwụ Eshia, South Korea, Japan na ahịa ndị ọzọ.Ọ na-enyekwa ọrụ ahịa na ịre ahịa na usoro dum site na etiti ruo na API ngwaahịa emechara.Jiri akụrụngwa nke Yangshi Chemical chịkọbara na kemịkalụ fluorine iji nyeọrụ nhazi kemịkalụ pụrụ ichemaka ndị mmekọ.Nye usoro ihe ọhụrụ na ọrụ nyocha adịghị ọcha iji lekwasị ndị ahịa anya.